TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios SVA
Line item Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q2 22 Q3 22 Q1 23 Q2 23 Q4 23
Valuation
– – – 166.1 99.2 614.8 – – – 210.9 – – 930.4 – – – 92.5 16.2 16.1 12.7 12.8 13.4 14.3 21.5 26.9 28.0 25.4 44.9 96.2 – – 4.2 2.6 0.1 0.1 – – – 16.1 –
3.8 3.5 4.8 5.4 6.1 5.1 4.8 4.6 4.8 4.6 4.4 5.9 6.4 8.4 6.5 4.6 3.4 2.4 2.5 1.9 2.0 1.7 1.9 2.7 2.7 3.9 3.2 3.6 4.0 4.4 3.7 1.4 0.9 0.1 0.0 – – – 0.2 –
1.8 1.8 2.6 2.7 3.2 2.5 2.1 2.3 2.3 2.3 2.3 2.6 3.0 3.0 2.9 2.9 2.5 3.0 3.5 3.0 3.3 2.7 2.1 2.2 2.1 2.8 2.4 2.3 2.3 2.3 2.4 1.0 1.0 0.1 0.1 0.1 0.1 – 0.1 0.1
3.0 2.8 4.1 4.9 5.3 4.5 4.2 4.0 4.3 4.1 4.0 5.3 5.9 7.9 6.1 4.4 3.2 2.3 2.4 1.6 1.7 1.5 1.4 2.1 2.0 3.1 2.5 2.8 3.1 3.7 3.3 -0.5 -0.3 -0.5 -0.5 – – – -0.2 –
– – 48.7 22.0 19.5 20.0 22.2 20.8 31.6 18.6 20.6 41.2 46.3 – – 77.4 – – – – 5.4 4.9 4.7 7.7 8.6 11.1 9.7 13.1 20.7 180.8 44.0 -1.1 -0.6 -0.6 -0.6 – – – – –
– – – – – – – – – – – – – – – – – – – – 13.4 13.8 11.3 – – – – – – – – 2.1 0.9 0.1 0.0 – – – – –
-12.4% -8.8% -4.4% -7.5% -6.4% -10.0% -11.7% -6.8% -7.7% -4.4% -3.5% -8.3% -8.3% -10.9% -10.9% -8.4% – – – – 7.4% 7.2% 8.9% -2.4% -3.1% -0.4% -0.8% -2.7% -4.6% -10.0% -12.6% 47.6% 107.8% 1,277.9% 2,084.8% – – – -233.5% –
Margins
62.8% 63.6% 66.7% 72.1% 73.1% 72.2% 74.1% 73.9% 73.6% 75.8% 74.8% 71.5% 68.4% 53.7% 64.1% 69.1% 77.2% 84.0% 82.7% 86.4% 87.6% 86.9% 89.3% 89.8% 88.7% 90.4% 88.1% 87.7% 87.2% 85.2% 87.1% 86.8% 86.8% 93.8% 94.2% – – – 34.3% –
-30.2% -17.4% -4.5% 7.1% 11.0% 3.6% 0.2% 0.8% -3.6% 7.8% 4.4% -0.5% 0.0% -45.1% -20.6% 0.7% 9.3% 22.3% 24.3% 25.9% 27.8% 27.1% 27.2% 23.5% 19.8% 24.7% 22.2% 17.2% 10.8% -2.8% 5.0% 42.2% 51.2% 89.8% 89.6% – – – -33.0% –
-22.4% -14.6% -5.3% 3.3% 6.1% 0.8% -3.0% -1.3% -5.3% 2.2% -0.4% -5.7% 0.7% -28.6% -12.8% -0.8% 3.7% 14.9% 15.4% 14.9% 15.3% 12.8% 13.4% 12.5% 9.9% 13.8% 12.6% 7.9% 4.2% -6.3% -3.0% 34.1% 35.1% 46.0% 43.7% – – – 1.4% –
-47.5% -31.2% -21.3% -40.7% -39.0% -51.0% -55.9% -31.2% -36.9% -20.3% -15.7% -48.9% -52.8% -91.5% -70.7% -38.8% – – – – 14.6% 12.4% 16.9% -6.4% -8.1% -1.7% -2.7% -9.6% -18.4% -43.6% -46.7% 68.9% 96.8% 80.6% 77.1% – – – -52.3% –
Returns
-10.3% -7.6% -2.9% 1.6% 3.2% 0.4% -1.4% -0.7% -2.5% 1.1% -0.2% -2.6% 0.3% -10.2% -5.8% -0.5% 2.7% 18.4% 21.7% 23.6% 25.5% 20.5% 15.0% 10.2% 7.7% 9.9% 9.5% 5.1% 2.4% -3.3% -1.9% 23.3% 38.7% 92.0% 93.8% – – – 0.5% –
-5.5% -4.0% -1.5% 0.9% 1.7% 0.2% -0.7% -0.4% -1.5% 0.6% -0.1% -1.5% 0.2% -6.3% -3.3% -0.3% 1.4% 9.8% 11.9% 11.9% 12.9% 10.9% 10.2% 7.0% 5.2% 6.5% 6.2% 3.3% 1.5% -1.7% -0.9% 9.2% 15.2% 42.8% 52.2% – – – 0.3% –
Balance Sheet & Debt
-46 -43 -51 -33 -48 -39 -35 -40 -30 -30 -26 -29 -27 -20 -17 -19 -18 -18 -6.9 -81 -77 -63 -144 -133 -135 -138 -144 -145 -145 -103 -90 -990 -998 -6,779 -11,594 -6,850 -4,267 – -1,421 -1,010
– – -8.8 -2.4 -2.6 -2.8 -3.4 -3.3 -3.8 -2.1 -2.1 -4.0 -3.6 – – -4.7 – – – – -1.0 -0.8 -1.7 -2.3 -2.9 -2.5 -2.8 -3.8 -6.0 -34.6 -6.1 -4.5 -2.3 -0.6 -0.6 – – – – –
53.8% 53.4% 53.5% 53.3% 53.3% 54.1% 51.9% 53.1% 58.7% 58.5% 60.5% 60.4% 60.4% 61.6% 56.4% 54.8% 53.1% 53.1% 54.8% 50.5% 50.5% 53.1% 68.5% 67.9% 67.9% 66.0% 64.9% 65.5% 65.5% 52.8% 46.5% 39.3% 39.3% 46.5% 55.7% 62.8% 63.2% – 63.1% 63.8%
0.4 0.4 0.4 0.5 0.4 0.4 0.5 0.4 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.5 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 – 0.0 0.0
Per Share
-0.22 -0.16 -0.07 0.04 0.07 0.01 -0.03 -0.02 -0.06 0.03 0.00 -0.06 0.01 -0.20 -0.12 -0.01 0.06 0.42 0.44 0.62 0.67 0.56 0.53 0.32 0.24 0.23 0.26 0.14 0.07 -0.09 -0.05 1.53 2.54 47.37 76.75 – – – 0.40 –
0.97 1.11 1.24 1.13 1.19 1.10 1.00 1.12 1.05 1.16 1.15 0.97 1.00 0.70 0.91 1.27 1.66 2.81 2.86 4.18 4.39 4.38 3.98 2.57 2.44 1.68 2.03 1.82 1.61 1.49 1.75 4.49 7.24 103.07 175.71 – – – 29.02 –
2.11 2.14 2.30 2.27 2.27 2.24 2.24 2.26 2.22 2.27 2.19 2.17 2.17 1.96 2.02 2.03 2.28 2.28 2.03 2.64 2.62 2.74 3.55 3.13 3.13 2.34 2.69 2.87 2.87 2.83 2.69 6.57 6.57 51.51 81.82 82.93 89.66 – 75.86 87.44
-0.46 -0.34 -0.26 -0.46 -0.46 -0.56 -0.56 -0.35 -0.39 -0.24 -0.18 -0.48 -0.53 -0.64 -0.65 -0.49 – – – – 0.64 0.54 0.67 -0.17 -0.20 -0.03 -0.05 -0.18 -0.30 -0.65 -0.82 3.09 7.00 83.06 135.51 – – – -15.18 –

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?